tirzepatide and potassium π§ Let's break the drug down using this mnemonic cloud!β β π Tirzepatide is a GLP-1 GIP agonist. β β π€But what exactly is glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP)? β β Tirzepatide
Description
Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021

Tirzepatide is a dual GLP-1/GIP receptor agonist used for weight loss, but some patients wonder if it slows stomach emptying
The weight loss drug semaglutide will be made available for prescription from 4 September 2023, in what its manufacturer, Novo Nordisk, has described as a controlled and limited launch of the drug

May help support appetite control

Here's what to ask your doctor.

Consulta online con un mdico de la UE y consigue tu receta de Tirzepatide en 24h por 25.
